News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Secondary Offering


3/21/2014 8:57:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT:TXMD) (the "Company"), a women’s health care product company, announced today the pricing of a previously announced underwritten secondary public offering of 9,000,000 shares of its common stock, offered at a price of $7.10 per share. All shares are offered by the selling stockholders, including certain members of management of the Company and certain of their and the Company’s affiliates. The Company will not sell any shares or receive any proceeds from the offering. The offering is expected to close on or about March 26, 2014, subject to the satisfaction of customary closing conditions. In addition, certain of the selling stockholders have granted the underwriters a 30-day option to purchase up to an aggregate of 1,350,000 additional shares of common stock.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES